Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
Gerald H. Mazurek(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Kenneth G. Castro(Emory University), John Jereb, Stefan Goldberg, Andrew Vernon(The University of Texas at El Paso), Phillip A. Lobue
PubMed
June 25, 2010
Cited by 1,140
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|321
Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis
|American Journal of Respiratory and Critical Care Medicine|2006|285